Shenzhen Salubris Pharmaceutical Co.
Shenzhen, China · $260.0M raised
- Headquarters
- Shenzhen
- Employees
- 1001–5000
- Business Model
- B2B
- Website
- salubrisbio.com
- Total Funding
- $260.0M
- Last Round
- $260.0M Private EquitySep 2020
- Rounds
- 1
About
Innovation-driven pharmaceutical company based in Shenzhen, China, focused on developing novel therapeutics including antibody and protein-based treatments.
Summary
Shenzhen Salubris Pharmaceutical Co. is a Biotech company based in Shenzhen, China. It has raised $260.0M in total across 1 round, most recently a $260.0M Private Equity round in Sep 2020. Investors include The Carlyle Group.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2020
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company